• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic lymphocytic leukemia.

作者信息

Chiorazzi Nicholas, Rai Kanti R, Ferrarini Manlio

机构信息

Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY 11030, USA.

出版信息

N Engl J Med. 2005 Feb 24;352(8):804-15. doi: 10.1056/NEJMra041720.

DOI:10.1056/NEJMra041720
PMID:15728813
Abstract
摘要

相似文献

1
Chronic lymphocytic leukemia.慢性淋巴细胞白血病
N Engl J Med. 2005 Feb 24;352(8):804-15. doi: 10.1056/NEJMra041720.
2
[Repertory of T lymphocytes in patients with stage A chronic lymphoid leukemia: revealed by monoclonal expansion of T cells in vivo].[A期慢性淋巴细胞白血病患者的T淋巴细胞库：体内T细胞单克隆扩增揭示]
Bull Cancer. 1994 Oct;81(10):897-9.
3
Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.通过对细胞周期、激活及凋亡相关基因的定量表达分析揭示慢性淋巴细胞白血病遗传亚组中不同发病机制的证据。
J Clin Oncol. 2005 Jun 1;23(16):3780-92. doi: 10.1200/JCO.2005.02.568. Epub 2005 May 2.
4
Perspectives in chronic lymphocytic leukemia biology and management.慢性淋巴细胞白血病生物学与治疗的展望
Hematol Oncol Clin North Am. 2004 Aug;18(4):927-43, x. doi: 10.1016/j.hoc.2004.04.002.
5
Activation antigens and signal transduction in lymphocyte activation.淋巴细胞激活中的激活抗原与信号转导。
Immunol Rev. 1987 Feb;95:1-194.
6
B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.B细胞受体向脂筏的转位及相关信号传导在慢性淋巴细胞白血病具有预后意义的重要亚组之间存在差异。
Cancer Res. 2005 Aug 15;65(16):7328-37. doi: 10.1158/0008-5472.CAN-03-1563.
7
[Chronic lymphoid leukemia. Diagnosis, course, prognosis, principles of treatment].[慢性淋巴细胞白血病。诊断、病程、预后及治疗原则]
Rev Prat. 1999 Mar 1;49(5):539-46.
8
[Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].[慢性淋巴细胞白血病。II. 利用细胞学和免疫学指标鉴别各种形式的慢性淋巴细胞白血病]
Vutr Boles. 1988;27(3):76-80.
9
[Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].[慢性B淋巴细胞白血病中淋巴细胞的免疫表型。I. 慢性淋巴细胞白血病中的B淋巴细胞和T淋巴细胞]
Acta Haematol Pol. 1992;23(1):21-7.
10
Surface immunoglobulin-mediated signal transduction involves rapid phosphorylation and activation of the protooncogene product Raf-1 in human B-cells.表面免疫球蛋白介导的信号转导涉及人类B细胞中原癌基因产物Raf-1的快速磷酸化和激活。
Cancer Res. 1992 Feb 1;52(3):566-70.

引用本文的文献

1
CLL cell-derived exosomes alter the immune and hematopoietic systems.慢性淋巴细胞白血病细胞衍生的外泌体改变免疫和造血系统。
Leukemia. 2025 Apr 4. doi: 10.1038/s41375-025-02590-x.
2
Hematopoietic progenitor kinase-1 inhibition improves the in vitro efficacy of bispecific antibodies in CLL.造血祖细胞激酶-1抑制可提高双特异性抗体在慢性淋巴细胞白血病中的体外疗效。
Blood Adv. 2025 Jun 24;9(12):2922-2926. doi: 10.1182/bloodadvances.2024015242.
3
Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL).
在慢性淋巴细胞白血病（CLL）患者中，评估不同剂量依鲁替尼对布鲁顿酪氨酸激酶（BTK）的抑制作用。
Cancer Chemother Pharmacol. 2025 Feb 28;95(1):38. doi: 10.1007/s00280-025-04753-0.
4
Association of Specific Gene Mutations with Immunoglobulin Heavy-Chain Variable Region and Chromosomal Alterations in Chronic Lymphocytic Leukemia Patients in India.印度慢性淋巴细胞白血病患者特定基因突变与免疫球蛋白重链可变区及染色体改变的关联
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):109-115. doi: 10.31557/APJCP.2025.26.1.109.
5
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.慢性淋巴细胞白血病：2025年流行病学、发病机制、诊断与治疗最新进展
Am J Hematol. 2025 Mar;100(3):450-480. doi: 10.1002/ajh.27546. Epub 2025 Jan 28.
6
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating Wild-Type Chronic Lymphocytic Leukemia.以Siremadlin靶向MDM2-p53相互作用：一种治疗野生型慢性淋巴细胞白血病的有前景的治疗策略。
Cancers (Basel). 2025 Jan 16;17(2):274. doi: 10.3390/cancers17020274.
7
West Nile Virus Encephalitis in a Patient with Chronic Lymphocytic Leukemia.一名慢性淋巴细胞白血病患者的西尼罗河病毒脑炎
Mediterr J Hematol Infect Dis. 2025 Jan 1;17(1):e2025010. doi: 10.4084/MJHID.2025.010. eCollection 2025.
8
JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL.JNK1 抑制剂靶向远端 B 细胞受体信号转导，并克服 CLL 中 BTK 抑制剂耐药性。
J Exp Med. 2025 Jan 6;222(1). doi: 10.1084/jem.20230681. Epub 2024 Nov 21.
9
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.从血液系统恶性肿瘤中p53的调控到去调控：对诊断、预后和治疗的影响
Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9.
10
Immunophenotyping of Peripheral Blood Cells in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.伊布替尼治疗的慢性淋巴细胞白血病患者外周血细胞免疫表型分析。
Cells. 2024 Aug 30;13(17):1458. doi: 10.3390/cells13171458.